Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Dr Reddys Laboratories Australia Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (303)
ARTG (234)
Prescription medicine registration (15)

Date

2024 (31)
2023 (161)
2022 (28)
2021 (55)
2020 (48)
2019 (26)
2018 (52)
2017 (35)
2016 (78)
2014 (2)
2013 (9)
2012 (16)
2011 (2)
2010 (9)

Results for "[search-keyword]"

Search

Sponsor content

552 result(s) found, displaying 451 to 460

CAPECITABINE ALPHAPHARM capecitabine 150 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

29 June 2018

Cancellation by sponsor

Requested by Dr Reddys Laboratories Australia Pty Ltd
CAPECITABINE ALPHAPHARM capecitabine 500 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

29 June 2018

Cancellation by sponsor

Requested by Dr Reddys Laboratories Australia Pty Ltd
TERRY WHITE CHEMISTS FEXOFENADINE fexofenadine hydrochloride 120mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

25 June 2018

Cancellation by sponsor

Requested by Dr Reddys Laboratories Australia Pty Ltd
CHEMMART FEXOFENADINE fexofenadine hydrochloride120mg film-coated tablets blister pack Cancelled under Section 30(1)(c) of the Act

25 June 2018

Cancellation by sponsor

Requested by Dr Reddys Laboratories Australia Pty Ltd
CHEMMART FEXOFENADINE fexofenadine hydrochloride 180mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

25 June 2018

Cancellation by sponsor

Requested by Dr Reddys Laboratories Australia Pty Ltd
Flora Balance Cancelled under Section 30(1)(c) of the Act

22 June 2018

Cancellation by sponsor

Requested by Dr Reddys Laboratories Australia Pty Ltd
Calcium Actavis Cancelled under Section 30(1)(c) of the Act

22 June 2018

Cancellation by sponsor

Requested by Dr Reddys Laboratories Australia Pty Ltd
PHARMACIST OWN FEXOFENADINE 180mg fexofenadine hydrochloride 180 mg film coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

22 June 2018

Cancellation by sponsor

Requested by Dr Reddys Laboratories Australia Pty Ltd
SERTRALINE-DRLA sertraline 50 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

22 June 2018

Cancellation by sponsor

Requested by Dr Reddys Laboratories Australia Pty Ltd
SERTRALINE-DRLA sertraline 100 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

22 June 2018

Cancellation by sponsor

Requested by Dr Reddys Laboratories Australia Pty Ltd

Pages

First page
Previous page
…
Page 42
Page 43
Page 44
Page 45
Current page 46
Page 47
Page 48
Page 49
Page 50
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.